Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;335:221 (4 August), doi:10.1136/bmj.39289.575058.BE
| The first 150 words of the full text of this article appear below. |
Goodyer et al tell us something about the role of cognitive behaviour therapy in adolescent depression but nothing about the use of drugs.1 The response rate is not strikingly different from what would be expected from placebo, and, as with other studies of combinations of antidepressant and cognitive behaviour therapy,2 we can draw no conclusions about the efficacy of antidepressants without a placebo arm. The authors justify its absence on the basis that a placebo arm would be unethical in such ill patients. That justification is questionable, given that at least 19 out of 20 studies of newer antidepressants in children and adolescents fail to show meaningful advantage of drug over placebo on their primary outcomes.3 Although Goodyer et al make few direct claims about the effectiveness of antidepressants, the implication that benefit is attributable to the drug will likely be used by others to support prescribing.
Jon N Jureidini, head
Department of Psychological Medicine, Women's and Children's Hospital, North Adelaide 5006, Australia
jon.jureidini@cywhs.sa.gov.au
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?